Please assess the completion status of the following clinical trial:

Trial Title: Using Affective Differences to Predict Response to Behavioral Treatment for Major Depressive Disorder

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy participants should have no lifetime history of psychiatric disorder~* Depressed participants should have a current diagnosis of major depressive disorder, as defined by the DSM-IV~Exclusion Criteria:~* History of bipolar affective disorder~* History of psychosis~* Current non-psychotic Axis I disorder, if it constitutes the predominant aspect of the clinical presentation and immediately requires treatment other than that offered in the study~* History of substance dependence within the past 6 months~* Antisocial, borderline, schizotypal, or schizoid personality disorders~* Evidence of any medical disorder or condition that could cause depression or preclude the use of study treatments~* Current treatment with catecholaminergic antihypertensive medication, such as reserpine, beta-blockers, clonidine, and alphamethyldopa~* Current use of antidepressant medication~* Clear indication of secondary gain~* Current suicide risk sufficient to preclude treatment on an outpatient basis~* Severe, unstable concurrent psychiatric conditions likely to require hospitalization within 6 months of study entry~* Already receiving a targeted psychotherapy aimed at depression

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 72 Years
- Healthy Volunteers: t

Study Arms:
- Current Major Depressive Disorder (Type: None): Forty-one participants with a primary diagnosis of major depression using the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) and scores \> 24 on the Inventory of Depressive Symptomatology-Clinician Rated (IDS-C; Rush et al., 1986) were enrolled into a treatment study at Northwestern University's Feinberg School of Medicine in Chicago, Illinois. This group will receive Behavioral Activation psychotherapy.
- Healthy Participants (Type: None): Another 36 participants with no lifetime psychiatric symptoms and scores \< 11 on the IDS-C were tracked prospectively, naturalistically, for 16 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).